Endava price target lowered to $13 from $15 at Guggenheim

Guggenheim lowered the firm’s price target on Endava (DAVA) to $13 from $15 and keeps a Buy rating on the shares. The firm sees “an undemanding valuation and relatively healthy free cash flow,” even if incremental improvements take more time, the analyst tells investors in a Q4 preview, adding that it expects Endava to raise the low end of its FY26 revenue growth outlook while maintaining the high end.